OrbiMed Israel GP Ltd.
10% Owner

OrbiMed Israel GP Ltd. insider trades: Adicet Bio (ACET) stock buys and sales

10% Owner, Adicet Bio Last trade Apr 8, 2026 26 Form 4 filings
$675K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2019
5
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where OrbiMed Israel GP Ltd. reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 8, 2026ACET↓ Sell$675K
Oct 8, 2025ACET↑ Buy$5.0M
May 15, 2024PHGE↓ Sell$9K
Jan 25, 2024ACET↑ Buy$7.5M
Jun 27, 2023ACET↑ Buy$1.8M
Feb 27, 2023PHGE↑ Buy$85K
Jan 3, 2023CMMB↓ Sell$1.2M
Jun 25, 2021NMTR↓ Sell$20.9M
Dec 2, 2020NVUS↓ Sell$2.2M
Dec 19, 2019PHGE↑ Buy$36K
Dec 11, 2019PHGE↑ Buy$78K
Dec 9, 2019PHGE↑ Buy$86K
May 2, 2019NVUS↑ Buy$2.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ACET insiders

Open-market trades in the last 12 months

About OrbiMed Israel GP Ltd.'s insider trades

OrbiMed Israel GP Ltd. is a 10% owner of Adicet Bio (ACET). Since May 2, 2019, it has reported 8 open-market purchases worth $16.6M and 5 sales worth $25.1M on SEC Form 4. In the last 12 months: 1 sale ($675K).

Its filings also include other transactions (7 filings), grants and awards (6 filings), option exercises (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACET insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.